Search research articles
Contact Us
Filters
Showing results (111-120 of 150) with videos related to
Page
of 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2023
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer
David Pook, Daniel M Geynisman, Joan Carles, et al.
Oncotarget
|
March 31, 2016
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma
Daniele Santini, Matteo Santoni, Alessandro Conti, et al.
Clinical Genitourinary Cancer
|
April 14, 2024
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study
Veronica Mollica, Francesco Massari, Marco Maruzzo, et al.
The Oncologist
|
July 3, 2026
The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study
Giuseppe Neola, Fabiano Flauto, Carmine Caso, et al.
Cancers
|
May 16, 2023
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
Sara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, et al.
Tumori
|
April 15, 2025
From walls to wonder: Talking about spaces tailored for adolescents and young adults with cancer
Carlo Alfredo Clerici, Francesca Scotti, Elena Pagani Bagliacca, et al.
Clinical & Experimental Metastasis
|
February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations
Michele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
Future Oncology (London, England)
|
June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Future Oncology (London, England)
|
April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Immunotherapy
|
January 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations
Matilde Corianò, Alessandro Lazzarin, Michele Maffezzoli, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 150) with videos related to
Sort By:
Page
of 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2023
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer
David Pook, Daniel M Geynisman, Joan Carles, et al.
Oncotarget
|
March 31, 2016
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma
Daniele Santini, Matteo Santoni, Alessandro Conti, et al.
Clinical Genitourinary Cancer
|
April 14, 2024
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study
Veronica Mollica, Francesco Massari, Marco Maruzzo, et al.
The Oncologist
|
July 3, 2026
The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study
Giuseppe Neola, Fabiano Flauto, Carmine Caso, et al.
Cancers
|
May 16, 2023
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
Sara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, et al.
Tumori
|
April 15, 2025
From walls to wonder: Talking about spaces tailored for adolescents and young adults with cancer
Carlo Alfredo Clerici, Francesca Scotti, Elena Pagani Bagliacca, et al.
Clinical & Experimental Metastasis
|
February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations
Michele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
Future Oncology (London, England)
|
June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Future Oncology (London, England)
|
April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Immunotherapy
|
January 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations
Matilde Corianò, Alessandro Lazzarin, Michele Maffezzoli, et al.
Page
of 15